Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.

Announcements

388

Total raised

£13.0B

disclosed amounts

Series B
£16.0M

Kayne Anderson Partners Fund V led the Series B round to support commercial growth in the United States.

"We are thrilled to partner with Arbolus at this pivotal stage in their growth and at such an opportune moment in this industry. As long users of expert networks ourselves, Arbolus’s differentiated and disruptive approach to a critical – but legacy – industry, supported by consistent growth, validates the strength of their offering."
— Leon Chen
Series B
£4.5M

The Series B round was led by NetmindAI with backing from WP Health.

"This successful round of funding is a clear validation of the market’s growing appetite for AI-powered hardware solutions. With the support of forward-thinking investors like NetMind.AI, we’re positioned to take our development and innovation in AI-driven hardware to new heights. This milestone not only fuels our ambition but also strengthens our commitment to delivering smarter, more intuitive technologies that transform human-machine interactions globally"
— Ming Kong, CEO & Co-founder
Series B
£10.0M

Mercia Ventures led the £10m Series B investment to support international expansion and product automation.

"Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient. With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care. We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem."
— Christoph Lippuner, CEO and Co-founder
Series B
$15.0M

The Series B round was led by HV Capital and Unbound, with participation from Cristiano Ronaldo, to fund global expansion.

"Backing Bioniq goes beyond just an investment opportunity for me—it’s about aligning with a shared vision for health, performance, and longevity. I have been using their products myself for almost three years. With their personalized health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer."
— Cristiano Ronaldo, Shareholder and Investor